Press coverage about Vascular Solutions (NASDAQ:VASC) has been trending somewhat positive recently, according to Accern Sentiment Analysis. The research firm ranks the sentiment of press coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Vascular Solutions earned a daily sentiment score of 0.07 on Accern’s scale. Accern also gave headlines about the medical device company an impact score of 46.1406739948754 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Vascular Solutions (VASC) remained flat at $$56.00 during trading on Wednesday. The stock had a trading volume of 1,213,900 shares, compared to its average volume of 248,891. Vascular Solutions has a twelve month low of $25.06 and a twelve month high of $57.15.

ILLEGAL ACTIVITY WARNING: This news story was originally reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this news story on another domain, it was stolen and republished in violation of United States and international copyright & trademark laws. The correct version of this news story can be viewed at https://theolympiareport.com/2017/12/27/somewhat-favorable-media-coverage-somewhat-unlikely-to-impact-vascular-solutions-vasc-share-price-2.html.

About Vascular Solutions

Vascular Solutions, Inc is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company’s product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world.

Insider Buying and Selling by Quarter for Vascular Solutions (NASDAQ:VASC)

Receive News & Ratings for Vascular Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vascular Solutions and related companies with MarketBeat.com's FREE daily email newsletter.